Inferra AI / Company / CMC
Commercial Metals Co
CMC · Materials
Last earnings Oct 15, 2026
Key results
Net incomefull-year
$655.8 million
99.1 News Release CMC REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2026 RESULTS Fiscal 2026 net earnings of $655.8 million.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Net incomequarter
$212.5 million
net earnings of $212.5 million, or $1.91 per diluted share, and adjusted earnings of $233.6 million, or $2.09 per diluted share Fourth quarter consolidated core EBITDA increased 35.1% year-over-year to $393.7 million and core EBITDA margin increased by 100 basis points to 14.8% Improved results were driven by strong gr
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
net earnings of $212.5 million or $1.91 per diluted share, up from $1.35 in the prior year period, due in part to a lower effective tax rate.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
AI analysis
Q4 FY2026 · reported Oct 15, 2026
Based on: Earnings release + Q4 FY2026 deck + parent 8-K + 10-K — transcript not held
Guidance · company-stated
No guidance located in the held release
Capital allocation
During the quarter, CMC repurchased 383,333 shares of common stock valued at $26.7 million in the aggregate.
Event summary
99.1 News Release CMC REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2026 RESULTS Fiscal 2026 net earnings of $655.8 million
Based on: Earnings release + Q4 FY2026 deck + parent 8-K + 10-K — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
During the quarter, CMC repurchased 383,333 shares of common stock valued at $26.7 million in the aggregate.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
As of August 31, 2026, $702.1 million remained available under the current share repurchase authorization.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
On October 13, 2026, the board of directors declared a quarterly dividend of $0.20 per share of CMC common stock payable to stockholders of record on October 28, 2026.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
The dividend, to be paid on November 11, 2026, will mark the 248 th consecutive quarterly payment by the Company.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
1 Net leverage adjusted for acquisitions is a non-GAAP financial measure and is defined as net debt divided by modified consolidated EBITDA, both of which are also non-GAAP financial measures.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Net debt is calculated as total debt minus cash and cash equivalents.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Strategy & priorities
We also established a clear roadmap to fiscal 2029, setting ambitious and achievable targets with a focus on delivering long-term shareholder value, said Peter Matt, President and Chief Executive Officer.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
With backlogs near record levels, a differentiated portfolio of solutions, and multiple value creation levers, we are well-positioned to deliver strong financial results and achieve our strategic goals in fiscal 2027.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Consolidated core EBITDA for the fiscal fourth quarter increased 35.1% year-over-year to $393.7 million, while core EBITDA margins expanded 100 basis points to 14.8%, driven by metal margin expansion and the inclusion of the higher-margin precast business.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Relative to the fiscal third quarter, 11.3% core EBITDA growth was led by the North America Steel Group, where stronger margins and volume growth drove 60 basis points of core EBITDA margin expansion.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Our focus remains on delivering profitable growth, improving free cash flow generation, enhancing shareholder returns, and, above all, continuing to advance our strategic agenda for a stronger CMC.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Risks & headwinds
Improved trade policies via the (CMC Fourth Quarter Fiscal 2026 - 4) EU Carbon Border Adjustment Mechanism ( CBAM ) as well as the tariff-rate quota ( TRQ ) system implemented July 1, 2026 are supporting a more constructive operating environment.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Modified consolidated EBITDA is calculated as adjusted EBITDA for the trailing 12-month period, adjusted to (a) eliminate the impact of approximately $15.4 million of interest expense related to the judgment in the Pacific Steel Group litigation, (b) eliminate actual results from the precast business since the respective acquisition dates and (c) include $212 million of annualized EBITDA contribution from the precast business.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
The adjustment Litigation expense represents a provision recorded in the three months ended November 30, 2024 related to the judgment in the Pacific Steel Group litigation and, with respect to subsequent periods, primarily represents interest expense on the judgment amount.
SEC original ↗Commercial Metals Co — Earnings release (8-K exhibit)EX-99Oct 15, 2026
Modified consolidated EBITDA is calculated as adjusted EBITDA for the applicable trailing 12-month period, adjusted to (a) eliminate the impact of the judgment in the Pacific Steel Group litigation and interest expense related to the judgment amount, (b) eliminate actual results from the precast business since the respective acquisition dates and (c) include an estimate of annualized EBITDA contribution from the precast business, which is $245 million for the Post Precast Closing, Q2 26 and Q3 26 figures and $212 million for the Q4 26 figure.
SEC original ↗Commercial Metals Co — Presentation / slide deck (8-K exhibit)EX-99Oct 15, 2026
Adjusted earnings also excludes litigation expense, unrealized (gain) loss on undesignated commodity hedges and acquisition, integration and financing related costs, amortization of acquired contract backlog and purchase accounting effect on inventory.
SEC original ↗Commercial Metals Co — Presentation / slide deck (8-K exhibit)EX-99Oct 15, 2026
Core EBITDA also excludes litigation expense, settlement for New Market Tax Credit transactions, non-cash stock-based compensation, loss on debt extinguishments, gains on sale of assets, acquisition settlements, acquisition and integration related costs, and purchase accounting effect on inventory.
SEC original ↗Commercial Metals Co — Presentation / slide deck (8-K exhibit)EX-99Oct 15, 2026
Earnings deck slides
0 decks with slide viewCommercial Metals Co — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Commercial Metals Co — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Commercial Metals Co — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Commercial Metals Co — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Commercial Metals Co — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documents- Q3 2026
- 10-KCMC
Oct 16, 2026
- 8-KCMC
Oct 15, 2026
- 8-KCMC
Oct 13, 2026
- Q2 2026
- 8-KCMC
Aug 5, 2026
- Q1 2026
- 10-QCMC
Jun 29, 2026
- 8-KCMC
Jun 25, 2026
- 8-KCMC
Jun 24, 2026
- 8-KCMC
Apr 13, 2026
- Q4 2025
- 10-QCMC
Mar 31, 2026
- 8-KCMC
Mar 26, 2026
- 8-KCMC
Mar 25, 2026
- EX-99CMC
Mar 25, 2026
- 8-K/ACMC
Feb 19, 2026
- 8-KCMC
Jan 15, 2026
- 10-QCMC
Jan 8, 2026
- 8-KCMC
Jan 8, 2026
- 8-KCMC
Jan 5, 2026
- Q3 2025
- 8-KCMC
Dec 17, 2025
- 8-KCMC
Dec 15, 2025
- 8-KCMC
Dec 1, 2025
- 8-KCMC
Nov 26, 2025
- 8-KCMC
Nov 13, 2025
- 8-KCMC
Nov 12, 2025
- 8-KCMC
Nov 5, 2025
- 8-KCMC
Nov 4, 2025
- 10-KCMC
Oct 16, 2025
- 8-KCMC
Oct 16, 2025
- 8-KCMC
Oct 16, 2025
- 8-KCMC
Oct 15, 2025
- Q2 2025
- 8-KCMC
Sep 30, 2025
- 8-KCMC
Sep 18, 2025
Earnings releases
12 documentsPresentations
5 documentsTranscripts
0 documentsNo transcripts for Commercial Metals Co are held in this edition of the library.
Mentioned by
8 companiesOther tracked companies whose held documents mention Commercial Metals Co by name or ticker. A mention is counted once per document, from the document text the library holds.
Syndax Pharmaceuticals Inc (SNDX)
“pment plus selling, general… …AML that was ongoing in the prior period and a reduction in CMC expenses due to the capitalization of inventory for commercial use. Third quarter 2025 selling, general and administrative expenses increased to $44.9… …Thi”
“ segment). ACQUISITIONS AND DIVESTITURES On July 6, 2022, we completed the acquisition of CMC Materials, Inc. (now known as… …solutions around the primary modules in the semiconductor manufacturing process and in the emerging area of advanced packagi”
“tices (“GLP”) guidance; • completion of extensive chemistry, manufacturing, and control (“CMC”) studies; • submission to the… …liquidity, default, or non-performance of financial institutions, including the U.S. government, and an impairment in the c”
“2.8 (2016) • ENPP3 is an extracellular nucleotide metabolizing enzyme… …design and expert CMC execution create scalable process and stable product Robust process Highly stable Supply chain Cell bank – well characterized, high titer Drug substance (DS”
“se in transversal activities related to increased chemistry, manufacturing and controls (“CMC”) and supply chain costs related to the progression of clinical trials and anticipation of future commercial launch; and…”
“$ (0.72) (0.78) Weighted-average common shares used to compute… …the CMC function. Sriram leads CMC efforts at the company, providing strategic and technical guidance for drug substance development and manufacturing opera”
Rhythm Pharmaceuticals, Inc. (RYTM)
“ite /body weight regulation; rare disease drug discovery 20-plus years experience leading CMC, supply chain planning and quality assurance and control 20-plus years leading global commercial strategy in rare…”
“manufacturing transition with the appointments of Ronald Dadino as Senior Vice President, CMC and Supply Chain, and Gloria Cosgrove as Senior Vice President, Global Quality, each bringing significant U.S.-based…”
See also the earnings calendar for every tracked company’s next earnings date.